ISRG vs. ABT, SYK, BSX, MDT, BDX, EW, DXCM, IDXX, RMD, and STE
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Abbott Laboratories (ABT), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability, earnings and community ranking.
Abbott Laboratories presently has a consensus target price of $120.70, indicating a potential upside of 14.70%. Intuitive Surgical has a consensus target price of $438.74, indicating a potential downside of 0.58%. Given Intuitive Surgical's stronger consensus rating and higher probable upside, equities analysts plainly believe Abbott Laboratories is more favorable than Intuitive Surgical.
In the previous week, Abbott Laboratories had 12 more articles in the media than Intuitive Surgical. MarketBeat recorded 43 mentions for Abbott Laboratories and 31 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 0.64 beat Abbott Laboratories' score of 0.63 indicating that Abbott Laboratories is being referred to more favorably in the media.
Abbott Laboratories has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500.
Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Intuitive Surgical has a net margin of 27.65% compared to Intuitive Surgical's net margin of 13.65%. Intuitive Surgical's return on equity of 20.32% beat Abbott Laboratories' return on equity.
75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 1.1% of Abbott Laboratories shares are held by company insiders. Comparatively, 0.9% of Intuitive Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Intuitive Surgical received 103 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.69% of users gave Abbott Laboratories an outperform vote while only 69.12% of users gave Intuitive Surgical an outperform vote.
Summary
Abbott Laboratories and Intuitive Surgical tied by winning 9 of the 18 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intuitive Surgical Competitors List
Related Companies and Tools
